Moreover, HIF-1α activation can alter metabolic pathways, promoting glycolysis and angiogenesis, which support tumor growth and survival in the hypoxic tumor microenvironment, leading to the progression of gastrointestinal cancers in individuals with obesity [70]. The gene discussed is HIF1A; the disease is neoplasm.